Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine + Methylprednisolone for Post-Craniotomy Pain in Children
NCT03636165Phase 4Unknown
- Sponsor
- Beijing Tiantan Hospital
- Start
- Sep 2022
- Primary completion
- Dec 2023
- Modality
- Orthosteric Ligands
01
Overview
Phase 4, randomised trial of methylprednisolone in postoperative pain (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Cumulative fentanyl consumption within 24 hours postoperatively. Status: unknown.
02
Drugs
methylprednisolone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03636165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03636165.